About YAMAKOSHI Shuhei
About Mitsubishi Tanabe Pharma Corp., Yokohama, JPN
About YAMAKOSHI Shuhei
About Hiroshima Univ., Hiroshima, JPN
About OKAMOTO Masako
About Mitsubishi Tanabe Pharma Corp., Yokohama, JPN
About SAWAMOTO Hiroaki
About Mitsubishi Tanabe Pharma Corp., Yokohama, JPN
About ARAI Yuuki
About Mitsubishi Tanabe Pharma Corp., Yokohama, JPN
About KAWANISHI Eiji
About Mitsubishi Tanabe Pharma Corp., Yokohama, JPN
About SASAKI Michiko
About Hiroshima Univ., Hiroshima, JPN
About TAKEDA Kei
About Hiroshima Univ., Hiroshima, JPN
About Current Organic Synthesis
About macrocyclic compound
About depsipeptide
About lactonization
About density functional method
About molecular dynamics
About stability
About internuclear distance
About Cyclodepsipeptide
About macrolactonization
About retrosynthetic analysis
About Bioactive compounds
About conformational stability
About DFT calculation
About conformational stability
About Peptides
About Electronic structure of molecules
About Neoantimycin
About (2S,3R)-2-(Boc-Amino)-3-(((2S,3S)-2-(2,2-dimethyl-3-oxo-4-(2-hydroxy-3-methylbutanoyloxy)-5-phenylpentanoyloxy)-3-methylpentanoyl)oxy)butyric acid
About (2S,13R,14S)-2-Isopropyl-5-benzyl-7,7,13-trimethyl-10-(1-methylpropyl)-14-(Boc-amino)-1,4,9,12-tetraoxacyclopentadecane-3,6,8,11,15-pentaone
About N-[(2S,13R,14S)-2-Isopropyl-3,6,8,11,15-pentaoxo-5-benzyl-7,7,13-trimethyl-10-(1-methylpropyl)-1,4,9,12-tetraoxacyclopentadecane-14-yl]-2-benzyloxy-3-(formylamino)benzamide
About N-[(2S,13R,14S)-2-Isopropyl-3,8,11,15-tetraoxo-5-benzyl-6-hydroxy-7,7,13-trimethyl-10-(1-methylpropyl)-1,4,9,12-tetraoxacyclopentadecane-14-yl]-2-benzyloxy-3-(formylamino)benzamide
About 環状
About デプシペプチド
About 計算
About 支援
About 切断法